Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Colon Cancer (Stage II &Amp;Amp;Amp; III)”

6 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 6 of 6 results

Large-scale testing (Phase 3)Looking for participantsNCT06609551
What this trial is testing

CtDNA-guided Selection of Adjuvant Chemotherapy Regimens for Elderly Colon Cancer Patients After Surgery: A Single-center, Randomized, Controlled Study

Who this might be right for
Colon CancerColon Cancer (Stage II &Amp;Amp;Amp; III)
Zhejiang Cancer Hospital 312
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07549906
What this trial is testing

Neoadjuvant Iparomlimab/Tuvonralimab Plus CAPEOX Versus Iparomlimab/Tuvonralimab Plus CAPEOX and Propranolol for Locally Advanced pMMR Colon Cancer: A Prospective, Single-Center, Multi-Cohort Study

Who this might be right for
Colon Cancer (Stage II &Amp; III)ImmunotherapyBeta Blocker+1 more
Sun Yat-sen University 45
Not applicableStudy completedNCT07012538
What this trial is testing

RASi for Preventing Postoperative Recurrence of Stage II/III Colon Cancer

Who this might be right for
Colon Cancer (Stage II &Amp;Amp; III)
Fudan University 2,640
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06890624
What this trial is testing

MFOLFOXIRI Plus PD-1 Inhibitor vs mFOLFOX6 as Neoadjuvant Therapy for Locally Advanced Colon Cancer

Who this might be right for
Colon Cancer (Stage II &Amp;Amp; III)
Sun Yat-sen University 138
Not applicableNot Yet RecruitingNCT07413146
What this trial is testing

Neoadjuvant CAPEOX Versus Upfront Surgery for Locally Advanced Colon Cancer With Elevated CEA: A Single-Center, Open-Label, Randomized Controlled Trial

Who this might be right for
Minimal Residual DiseaseImmunoscoreNeoadjuvant Chemotherapy+1 more
Sun Yat-sen University 100
Not applicableStudy completedNCT01346280
What this trial is testing

Evaluation of Cancer Care Coordination in the National Cancer Institutes Community Cancer Center Programs

Who this might be right for
Non-Small Cell Lung Cancer (Stage III)Colon Cancer (Stage II &Amp; III)Rectal Cancer (Stage III)
National Cancer Institute (NCI) 1,079